Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in Transplant Immunology
- Vol. 3 (3) , 203-211
- https://doi.org/10.1016/0966-3274(95)80026-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- INFLAMMATORY MEDIATOR RELEASE FROM HUMAN MONOCYTES VIA IMMOBILIZED Fc RECEPTORSTransplantation, 1992
- Cloning of the γ Chain of the Human IL-2 ReceptorScience, 1992
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurinNature, 1992
- The T cell receptor/CD3 complex is composed of at least two autonomous transduction modulesCell, 1992
- EFFECT OF ANTI-LFA1 (CD11a) MONOCLONAL ANTIBODIES IN ACUTE REJECTION IN HUMAN KIDNEY TRANSPLANTATIONTransplantation, 1991
- Interleukin-2 and the IL-2 Receptor: New Insight Into Structure and FunctionJournal of Investigative Dermatology, 1990
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing LinkAnnual Review of Immunology, 1990
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981